Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T70167 |
BP-5-087
|
Others | Others |
BP-5-087 is a STAT3 inhibitor, combining with BCR-ABL1 inhibition to overcome kinase-independent resistance in chronic myeloid leukemia. |